<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03513744</url>
  </required_header>
  <id_info>
    <org_study_id>JEN/008017</org_study_id>
    <nct_id>NCT03513744</nct_id>
  </id_info>
  <brief_title>Study Evaluating Growth and Tolerance of Infant Formula Containing HMOs</brief_title>
  <official_title>Evaluation of Nutritional Suitability and Tolerability of a Human Milk Oligosaccharide (HMO) Mix in Infant Formula for Term Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jennewein Biotechnologie GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Analyze &amp; Realize</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Jennewein Biotechnologie GmbH</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this clinical study is to investigate the suitability of an infant&#xD;
      formula containing five different human milk oligosaccharides to support normal physical&#xD;
      growth (evaluated per weight gain), in comparison with infant formula without human milk&#xD;
      oligosaccharides, when the formula is fed as the sole source of nutrition.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main goal of the study is to investigate the suitability of an infant formula containing&#xD;
      five different human milk oligosaccharides to support normal physical growth of term infants&#xD;
      (evaluated per weight gain, body length and head circumference), in comparison with infant&#xD;
      formula without human milk oligosaccharides, when the formula is fed exclusivly in the first&#xD;
      four month of life. Additionally, a comparison of the two formula fed groups against a&#xD;
      reference group with breastfed infants as well as the WHO growth standard reference tables&#xD;
      will be performed. An assessment of safety and tolerability will be performed as well.&#xD;
&#xD;
      As a secondary out come of the study, we will examine the effect of the formula on the infant&#xD;
      microbiome, as well as the HMO status of the mother's milk towards the microbial composition&#xD;
      of the infant microbiome.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 19, 2018</start_date>
  <completion_date type="Anticipated">April 2021</completion_date>
  <primary_completion_date type="Actual">March 3, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>assessment of body weight (in grams) of term infants</measure>
    <time_frame>4 month</time_frame>
    <description>growth, assessed by body weight gain, of term infants from enrollment to 4 month of life</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>assessment of body length (in centimeter) of term infants</measure>
    <time_frame>4 month</time_frame>
    <description>growth, assessed as body length, of term infants from enrollment to 4 month of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>assessment of head circumference (in centimeter) of term infants</measure>
    <time_frame>4 month</time_frame>
    <description>growth, assessed as head circumference, of term infants from enrollment to 4month of life</description>
  </secondary_outcome>
  <other_outcome>
    <measure>digestive tolerance</measure>
    <time_frame>4 month</time_frame>
    <description>stool frequency and consistency</description>
  </other_outcome>
  <other_outcome>
    <measure>influence of digestion</measure>
    <time_frame>4 month</time_frame>
    <description>digestive tolerance parameters ( e.g. rigurgitation, flatulence) will be assessed</description>
  </other_outcome>
  <other_outcome>
    <measure>influence on behaviour</measure>
    <time_frame>4 month</time_frame>
    <description>behavior patterns (e.g.fussiness, cramps, awakings at night) will be assessed</description>
  </other_outcome>
  <other_outcome>
    <measure>product compliance</measure>
    <time_frame>4 month</time_frame>
    <description>intake of infant formula in ml</description>
  </other_outcome>
  <other_outcome>
    <measure>morbidity</measure>
    <time_frame>4 month</time_frame>
    <description>observation of illness</description>
  </other_outcome>
  <other_outcome>
    <measure>stool microbiota</measure>
    <time_frame>4 month</time_frame>
    <description>analysis of the fecal microbiota</description>
  </other_outcome>
  <other_outcome>
    <measure>HMO composition in breast milk</measure>
    <time_frame>4 month</time_frame>
    <description>analysis of HMO composition in mothers breastmilk in the breast-fed arm</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Infant Nutrition</condition>
  <arm_group>
    <arm_group_label>infant formula containing five HMOs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>infant formula</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>breast milk group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>human milk oligosaccharides</intervention_name>
    <description>mixture of five different human milk oligosaccharides</description>
    <arm_group_label>infant formula containing five HMOs</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Singleton birth&#xD;
&#xD;
          -  Full-term infant (37 - 42 weeks of gestational age)&#xD;
&#xD;
          -  APGAR score of 9 or 10&#xD;
&#xD;
          -  Birth weight 2500 - 4500 g&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  clinically significant condition/ disorder&#xD;
&#xD;
          -  Adverse maternal of fetal medical history that may influence growth/development of the&#xD;
             subject or tolerance of the infant formula&#xD;
&#xD;
          -  readmission to hospital (except for hyperbilirubinemia)&#xD;
&#xD;
          -  allergy to cow's milk&#xD;
&#xD;
          -  participation in another study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>13 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frank Jochum, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaetsmedizin Berlin, Charité</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Facharzt für Kinder und Jugendmedizin</name>
      <address>
        <city>Mannheim</city>
        <zip>68161</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Südstadt Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>18059</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Spedali Civili di Brescia - Presidio Ospedale dei Bambini</name>
      <address>
        <city>Brescia</city>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Raffaele</name>
      <address>
        <city>Milan</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital HM Puerta del Sur</name>
      <address>
        <city>Madrid</city>
        <zip>28015</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital HM Monteprincipe</name>
      <address>
        <city>Madrid</city>
        <zip>28660</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital HM Nuevo Belen</name>
      <address>
        <city>Madrid</city>
        <zip>28938</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Sant Joan de Reus</name>
      <address>
        <city>Reus</city>
        <zip>43204</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Joan XXII of Tarragona</name>
      <address>
        <city>Tarragona</city>
        <zip>43005</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>April 12, 2018</study_first_submitted>
  <study_first_submitted_qc>April 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 2, 2018</study_first_posted>
  <last_update_submitted>March 3, 2021</last_update_submitted>
  <last_update_submitted_qc>March 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>human milk oligosaccharides</keyword>
  <keyword>infant formula</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

